4-56467655-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006947.4(SRP72):c.20G>A(p.Gly7Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,561,382 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G7G) has been classified as Benign.
Frequency
Consequence
NM_006947.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRP72 | NM_006947.4 | c.20G>A | p.Gly7Glu | missense_variant | 1/19 | ENST00000642900.1 | NP_008878.3 | |
SRP72 | NM_001267722.2 | c.20G>A | p.Gly7Glu | missense_variant | 1/17 | NP_001254651.1 | ||
SRP72 | XM_024454192.2 | c.20G>A | p.Gly7Glu | missense_variant | 1/17 | XP_024309960.1 | ||
SRP72 | NR_151856.2 | n.39G>A | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRP72 | ENST00000642900.1 | c.20G>A | p.Gly7Glu | missense_variant | 1/19 | NM_006947.4 | ENSP00000495128 | P1 | ||
SRP72 | ENST00000510663.6 | c.20G>A | p.Gly7Glu | missense_variant | 1/17 | 1 | ENSP00000424576 | |||
SRP72 | ENST00000504757.2 | c.20G>A | p.Gly7Glu | missense_variant | 1/5 | 2 | ENSP00000473576 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152140Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000115 AC: 23AN: 199632Hom.: 0 AF XY: 0.000135 AC XY: 15AN XY: 110750
GnomAD4 exome AF: 0.000114 AC: 160AN: 1409242Hom.: 0 Cov.: 30 AF XY: 0.000129 AC XY: 90AN XY: 699872
GnomAD4 genome AF: 0.000118 AC: 18AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2023 | The c.20G>A (p.G7E) alteration is located in exon 1 (coding exon 1) of the SRP72 gene. This alteration results from a G to A substitution at nucleotide position 20, causing the glycine (G) at amino acid position 7 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 09, 2017 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 7 of the SRP72 protein (p.Gly7Glu). This variant is present in population databases (rs139502866, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SRP72-related conditions. ClinVar contains an entry for this variant (Variation ID: 349113). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 01, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Autosomal dominant aplasia and myelodysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at